UCLA Health - 10 Questions About Thyroid RFA

Short Summary

Main recommendation: Thyroid radiofrequency ablation (thyroid RFA) is presented as a minimally invasive, outpatient option for treating mostly benign thyroid nodules that cause symptoms from size or excess hormone production. RFA stands for radiofrequency ablation, which uses a small needle electrode to heat and destroy abnormal tissue, and the speakers say it is effective and safe, leaves no scar, and does not affect thyroid function overall.

Key Points

• The speakers, UCLA radiologists Dr. Michael Dueck and Dr. David Liu, frame the video as answers to 10 popular questions about thyroid RFA.
• Thyroid nodules are very common: up to 70 percent of women and 40 percent of men have sonographically detected nodules, and about 95 percent of these are benign.
• RFA is best suited to mostly benign nodules that cause problems from their size (such as trouble swallowing, fullness in the neck, or cosmetic concerns) or from producing too much thyroid hormone (hot or functioning nodules).
• For predominantly cystic nodules, the speakers say injecting a small amount of alcohol as a sclerosing agent to scar the nodule works better than RFA, and UCLA offers that procedure too.
• After treatment, nodules gradually shrink: about 20 to 30 percent at one month, and roughly 70 to 80 percent volume reduction by about six months, with symptoms typically resolving.
• Early data suggests RFA may treat very small thyroid cancers, but the speakers stress this is only done after full discussion with the surgeon and patient.

Details Worth Noting

• Concrete instructions: Before the procedure, patients should have a formal consultation covering laboratory results, contraindications, and any biopsy results to confirm the nodule is not cancerous. A planning ultrasound maps out how the procedure will be done, and a consultation with a UCLA endocrinologist and/or endocrine surgeon is encouraged if not already done. Patients should expect an outpatient procedure with local anesthetic (a mild sedative may be requested), lasting about one hour, shorter for small nodules and a bit longer for large ones. Ultrasound guidance is used throughout, and afterward patients have only a small band-aid at the skin. Immediately after, patients may have very minor discomfort, and most have no activity limitations.
• The procedure works by moving the needle electrode to treat overlapping spots until the whole nodule is covered, with ultrasound showing the bright echogenic response at the needle tip to confirm adequate treatment before moving on.
• For hot nodules, the speakers say RFA can bring patients to a euthyroid state (no excess hormone), reported as successful in up to 80 percent of patients with small nodules and up to 50 percent with larger lesions. Traditional alternatives are surgery or radioiodine therapy.
• Patients with pre-existing conditions such as Hashimoto's thyroiditis may still need thyroid medication, but the speakers say this is not caused by the procedure.
• The speakers state the puncture site closes within days and leaves no scar.
• Insurance coverage is increasingly available, and the UCLA team works with each patient's insurer to confirm coverage before scheduling.

Bottom Line

Thyroid RFA is presented as a practical, low-risk option for symptomatic benign thyroid nodules, especially hot nodules, with results that build over several months and a clinic-based evaluation to determine suitability.